Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

u-blox AG: u-blox to host Capital Markets Day
u-blox AG: u-blox to host Capital Markets Day
u-blox AG: u-blox to host Capital Markets Day
u-blox AG: u-blox announces results of Extraordinary Shareholder’s Meeting
u-blox AG: u-blox announces results of Extraordinary Shareholder’s Meeting
u-blox AG: u-blox announces results of Extraordinary Shareholder’s Meeting
Energy transition and sustainability at the forefront of our thinking
Energy transition and sustainability at the forefront of our thinking
Energy transition and sustainability at the forefront of our thinking
Kardex adjusts margin target for 2022
Kardex adjusts margin target for 2022
Kardex adjusts margin target for 2022
EQS-News: Significantly positive sales development at the Highlight Group
EQS-News: Significantly positive sales development at the Highlight Group
EQS-News: Significantly positive sales development at the Highlight Group
Key Figures

15.11.2022
Key Figures 15.11.2022
Key Figures 15.11.2022
GeNeuro Announces Recruitment of First Patients in All Five Swiss Centers in the First Personalized Medicine Clinical Trial Against Long-COVID Assessing Temelimab: https://mms.businesswire.com/media/20210924005283/en/519367/5/GeNeuro_-_logo.jpg
GeNeuro Announces Recruitment of First Patients in All Five Swiss Centers in the First Personalized Medicine Clinical Trial Against Long-COVID Assessing Temelimab


GeNeuro (Paris:GNRO)(Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company focused on stopping causal factors driving the progression of neurodegenerative and autoimmune diseases such

GeNeuro meldet erste Patientenrekrutierungen in allen fünf schweizerischen Zentren für die erste klinische Studie mit Temelimab zur personalisierten Medizin gegen Long COVID: https://mms.businesswire.com/media/20210924005283/en/519367/5/GeNeuro_-_logo.jpg
GeNeuro meldet erste Patientenrekrutierungen in allen fünf schweizerischen Zentren für die erste klinische Studie mit Temelimab zur personalisierten Medizin gegen Long COVID


GeNeuro (Euronext Paris: CH0308403085 - GNRO), ein biopharmazeutisches Unternehmen, das sich darauf konzentriert, die kausalen Faktoren zu stoppen, die das Fortschreiten von neurodegenerativen und

GeNeuro Announces Recruitment of First Patients in All Five Swiss Centers in the First Personalized Medicine Clinical Trial Against Long-COVID Assessing Temelimab: https://mms.businesswire.com/media/20210924005283/en/519367/5/GeNeuro_-_logo.jpg
GeNeuro Announces Recruitment of First Patients in All Five Swiss Centers in the First Personalized Medicine Clinical Trial Against Long-COVID Assessing Temelimab


GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company focused on stopping causal factors driving the progression of neurodegenerative and autoimmune diseases such as multiple

Orascom Development Holding AG: has released its consolidated financial results for 9M 2022
Orascom Development Holding AG: has released its consolidated financial results for 9M 2022
Orascom Development Holding AG: has released its consolidated financial results for 9M 2022
Comet confirms growth targets at Capital Markets Day, short-term softening expected
Comet confirms growth targets at Capital Markets Day, short-term softening expected
Comet confirms growth targets at Capital Markets Day, short-term softening expected
EQS-News: Highlight Communications AG: Personnel
EQS-News: Highlight Communications AG: Personnel
EQS-News: Highlight Communications AG: Personnel
Cicor strengthens presence in Germany through the acquisition of Phoenix Mecano Digital Elektronik and Phoenix Mecano Digital Tunisie
Cicor strengthens presence in Germany through the acquisition of Phoenix Mecano Digital Elektronik and Phoenix Mecano Digital Tunisie
Cicor strengthens presence in Germany through the acquisition of Phoenix Mecano Digital Elektronik and Phoenix Mecano Digital Tunisie
Phoenix Mecano streamlines its Industrial Components business
Phoenix Mecano streamlines its Industrial Components business
Phoenix Mecano streamlines its Industrial Components business
Orascom Development Holding AG:  announces its Egyptian Subsidiary (ODE) 9M 2022 Financial Results
Orascom Development Holding AG: announces its Egyptian Subsidiary (ODE) 9M 2022 Financial Results
Orascom Development Holding AG: announces its Egyptian Subsidiary (ODE) 9M 2022 Financial Results
Implenia extends syndicated loan agreement and secures long-term financing
Implenia extends syndicated loan agreement and secures long-term financing
Implenia extends syndicated loan agreement and secures long-term financing
ZÜBLIN IMMOBILIEN HOLDING AG / Publication of Semi-Annual Report 2022/23 as of 30 September 2022
ZÜBLIN IMMOBILIEN HOLDING AG / Publication of Semi-Annual Report 2022/23 as of 30 September 2022
ZÜBLIN IMMOBILIEN HOLDING AG / Publication of Semi-Annual Report 2022/23 as of 30 September 2022
Evolva receives approval for Veri-teTM Resveratrol for animal health in Brazil
Evolva receives approval for Veri-teTM Resveratrol for animal health in Brazil
Evolva receives approval for Veri-teTM Resveratrol for animal health in Brazil
Swiss Steel Group saw expected slowdown in activity in Q3 2022
Swiss Steel Group saw expected slowdown in activity in Q3 2022
Swiss Steel Group saw expected slowdown in activity in Q3 2022
Meyer Burger successfully completes its capital increase of CHF 250 million
Meyer Burger successfully completes its capital increase of CHF 250 million
Meyer Burger successfully completes its capital increase of CHF 250 million
Meyer Burger announces 97.23 percent of the maximum number of offered shares were subscribed via the exercise of rights
Meyer Burger announces 97.23 percent of the maximum number of offered shares were subscribed via the exercise of rights
Meyer Burger announces 97.23 percent of the maximum number of offered shares were subscribed via the exercise of rights
LEM announces results for H1 2022/23: record sales and EBIT
LEM announces results for H1 2022/23: record sales and EBIT
LEM announces results for H1 2022/23: record sales and EBIT
CREALOGIX’ new research suggests investors want support to adopt crypto
CREALOGIX’ new research suggests investors want support to adopt crypto
CREALOGIX’ new research suggests investors want support to adopt crypto
Private Equity Holding AG: Half Year-Report as of September 30, 2022
Private Equity Holding AG: Half Year-Report as of September 30, 2022
Private Equity Holding AG: Half Year-Report as of September 30, 2022
Phoenix Mecano posts further increase in profitability
Phoenix Mecano posts further increase in profitability
Phoenix Mecano posts further increase in profitability